104 related articles for article (PubMed ID: 36971229)
1. The effect of nursing intervention combined with PD-1 inhibitor on platelets, white blood cells, tumor markers and quality of life in patients with lung cancer.
Liu J; Wang A; Zhang X; You X; Wang Y
Biotechnol Genet Eng Rev; 2023 Mar; ():1-15. PubMed ID: 36971229
[TBL] [Abstract][Full Text] [Related]
2. Effect of Psychological Intervention Combined with Dietary Guidance on Quality of Life and Long-Term Efficacy of Bushen Quyu Decoction in Treatment of Patients with Advanced Ovarian Cancer.
Liu D; Shi G; Yin C; Liu Z; Yang A
Evid Based Complement Alternat Med; 2021; 2021():1075513. PubMed ID: 34733335
[TBL] [Abstract][Full Text] [Related]
3. Effects of Traditional Chinese Medicine Anticancer Decoction Combined with Basic Chemotherapy and Nursing Intervention on Oral Cancer Patients after Surgery and Its Effect on Tumor Markers and Immune Function.
Jiang D; Xiao F; Liu L; Meng Z; Zhang C
Biomed Res Int; 2022; 2022():6341381. PubMed ID: 35402612
[TBL] [Abstract][Full Text] [Related]
4. Moxibustion for alleviating side effects of chemotherapy or radiotherapy in people with cancer.
Zhang HW; Lin ZX; Cheung F; Cho WC; Tang JL
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD010559. PubMed ID: 30480754
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors.
Zhang Z; Yuan F; Chen R; Li Y; Ma J; Yan X; Wang L; Zhang F; Tao H; Guo D; Huang Z; Zhang S; Li X; Zhi X; Ge X; Hu Y; Wang J
Front Immunol; 2020; 11():1173. PubMed ID: 32587591
[No Abstract] [Full Text] [Related]
6. Clinical Effects of Chinese Herbal Decoction Combined with Basic Chemoradiotherapy and Nursing Intervention in the Treatment of Cervical Cancer and the Effect on Serum CEA, CA125, and TNF-
Gao L; Lv J; Hou L; Yuan Y; Wan Q
Evid Based Complement Alternat Med; 2021; 2021():1446864. PubMed ID: 34603461
[TBL] [Abstract][Full Text] [Related]
7. Analysis of clinical efficacy and long-term prognosis of patients with hepatocellular carcinoma treated with PD-L1 inhibitor targeting.
Si T; Guo Y; Yang M
Technol Health Care; 2024 May; ():. PubMed ID: 38820031
[TBL] [Abstract][Full Text] [Related]
8. Endostatin induces normalization of blood vessels in colorectal cancer and promotes infiltration of CD8+ T cells to improve anti-PD-L1 immunotherapy.
Chu XD; Bao H; Lin YJ; Chen RX; Zhang YR; Huang T; He JS; Huangfu SC; Pan YL; Ding H
Front Immunol; 2022; 13():965492. PubMed ID: 36389685
[TBL] [Abstract][Full Text] [Related]
9. Effects of Traditional Chinese Medicine for Vaginal Lavage Combined with Psychological Intervention in Postoperative Patients with Cervical Cancer.
Ma R; Yu R; Yuan Y; Ren B; Li Y
Evid Based Complement Alternat Med; 2021; 2021():5751795. PubMed ID: 34956380
[TBL] [Abstract][Full Text] [Related]
10. [Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases].
Gu YC; Liu Y; Xie C; Cao BS
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 54(2):369-375. PubMed ID: 35435206
[TBL] [Abstract][Full Text] [Related]
11. To Explore the Effects of Acupuncture and Medical Treatment at Different Times on the Gastrointestinal Reaction and White Blood Cell Count of Patients with Lung Cancer Chemotherapy.
Zhao Q; Du H; Liu J; Hua Y; Niu X; Chen J
Appl Bionics Biomech; 2022; 2022():5261344. PubMed ID: 35432592
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of traditional Chinese Medicine combined with chemotherapy in patients with non-small cell lung cancer (NSCLC): a meta-analysis of randomized clinical trials.
Yang J; Zhu X; Yuan P; Liu J; Wang B; Wang G
Support Care Cancer; 2020 Aug; 28(8):3571-3579. PubMed ID: 32266566
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Evaluation of CT Imaging Big Data-Assisted Arterial Chemoembolization Combined with
Xie P; Zhang Y; He L
Comput Math Methods Med; 2022; 2022():3472982. PubMed ID: 35872936
[TBL] [Abstract][Full Text] [Related]
14. [Effects of chemotherapy combined with Chinese herbal medicine Kangliu Zengxiao decoction on tumor markers of patients with advanced non-small-cell lung cancer: a randomized, controlled trial].
Yan GY; Xu ZY; Deng HB; Wan ZY; Zhang L; Zhu JY
Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):525-30. PubMed ID: 21565138
[TBL] [Abstract][Full Text] [Related]
15. Effect of Sintilimab combined with Chemotherapy on Tumor Markers and Immune Function of advanced non-small cell lung cancer.
Liang X; Wei Z
Pak J Med Sci; 2021; 37(4):1063-1068. PubMed ID: 34290784
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: a systematic review and meta-analysis.
Liu W; Zhang Q; Zhang T; Li L; Xu C
World J Surg Oncol; 2022 Oct; 20(1):333. PubMed ID: 36192730
[TBL] [Abstract][Full Text] [Related]
17. The Effect of PD-1 Inhibitor Combined with Chemotherapy on the Level of Peripheral Blood T Lymphocytes among Patients with Non-Small-Cell Lung Cancer and Its Relationship with Prognosis.
Zhao Y; He J; Zhou S; Ning R; Zhao W; Wang H; Su C; Jiang W; Zhong X; Yu Q
Comput Math Methods Med; 2022; 2022():1679191. PubMed ID: 36118825
[TBL] [Abstract][Full Text] [Related]
18. [Effect of dendritic cells on immune function regulated by programmed cell death-1/programmed cell death-ligand 1 in sepsis].
Wang Z; Xie Z; Zhao Y; Bu T; Yu A; Wang S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Sep; 33(9):1032-1039. PubMed ID: 34839857
[TBL] [Abstract][Full Text] [Related]
19. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013257. PubMed ID: 33930176
[TBL] [Abstract][Full Text] [Related]
20. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
